Results 231 to 240 of about 2,748,163 (380)

Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) [PDF]

, 2000
Alastair Gray
openalex   +1 more source

Home‐Based Tele‐tDCS in Amyotrophic Lateral Sclerosis: Feasibility, Safety, and Preliminary Efficacy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with limited treatment options. Transcranial direct current stimulation (tDCS) shows promise as a neuromodulatory intervention in various neurological disorders, but its application in ALS, particularly in a remote, home‐based format, remains underexplored.
Sangeetha Madhavan, Shravni Deshmukh, Mark Cummings, Aditi Doshi, Kourosh Rezania, Sally Freels, Gina Sawa   +6 more
wiley   +1 more source

WHO SHOULD BE TRANSPLANTED WITH KIDNEYS FROM IDEAL DONORS VERSUS MARGINAL DONORS?: A COST-EFFECTIVENESS ANALYSIS

, 1998
Viken Douzdjian, G. Mark Baillie, C. Martin Bunke   +2 more
openalex   +1 more source

Management and Outcomes in Confirmed or Suspected Acute Symptomatic Seizure: Role of Structured Outpatient Care

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Post‐discharge management and outcomes of acute symptomatic seizures (ASyS) remain underexplored. We analyzed post‐discharge ASM management and outcomes in ASyS patients undergoing continuous EEG (cEEG), including the role of outpatient care through a post‐acute symptomatic seizure (PASS) clinic. Methods We performed a single‐center,
Vineet Punia, MarieElena Byrnes, Nicolas R. Thompson, Neishay Ayub, Clio Rubinos, Sahar Zafar, Adithya Sivaraju, Zhong Ying, Jessica R. Fesler, Stephen Hantus, Post‐Acute Symptomatic Seizure Investigation and Outcomes Network (PASSION) investigators   +10 more
wiley   +1 more source

Cost-effectiveness analysis of nephroprotection programs for patients with type 2 diabetes mellitus in insurers in Colombia. [PDF]

Cost Eff Resour Alloc
González-Rojas CA, Cáceres-Maldonado SA, Soler-Vanoy LA, Acuña-Merchán LA.   +3 more
europepmc   +1 more source

Is Cost-Effectiveness Analysis Unfair? [PDF]

Medical Decision Making, 2004
openaire   +3 more sources

Patients' Global Impression of Change (PGIC) Score Compared to Monthly Migraine Days to Evaluate Treatment Persistence With Anti‐CGRP Monoclonal Antibodies

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT This study assessed whether continued treatment with anti‐CGRP monoclonal antibodies (mAbs) is driven more by reductions in monthly migraine days (MMDs) or patients' global impression of change (PGIC), a patient‐reported outcome. Among 169 patients treated with anti‐CGRP mAbs, 21.3% discontinued due to ineffectiveness. PGIC responders (≥ 5) at
Marina Romozzi, Catello Vollono, Paolo Calabresi, Francesco De Cesaris, Luigi Francesco Iannone   +4 more
wiley   +1 more source

Effect of comprehensive cardiac telerehabilitation on one-year cardiovascular rehospitalization rate, medical costs and quality of life: A cost-effectiveness analysis

European Journal of Preventive Cardiology, 2016
I. Frederix, D. Hansen, K. Coninx, P. Vandervoort, D. Vandijck, N. Hens, E. V. Van Craenenbroeck, Niels Van Driessche, P. Dendale   +8 more
semanticscholar   +1 more source

Cost-effectiveness analysis of artificial intelligence-aided colonoscopy for adenoma detection and characterization in Spain. [PDF]

Endosc Int Open
Bustamante-Balén M, Merino Rodríguez B, Barranco L, Monje J, Álvarez M, de Pedro S, Oyagüez I, Van Lent N, Mareque M.   +8 more
europepmc   +1 more source

Cost-effectiveness Analysis of Breast Cancer Screening for Japanese Women Using Mammography and Physical Examination

, 1995
Takeshi Iinuma, Tohru Matsumoto, C Kido
openalex   +2 more sources